Sophie Wildner
About
In The Last Decade
Sophie Wildner
12 papers receiving 182 citations
Peers
Comparison fields: 5 of 51
- Infectious Diseases 74
- Molecular Biology 63
- Neurology 38
- Immunology 35
- Oncology 32
Countries citing papers authored by Sophie Wildner
This map shows the geographic impact of Sophie Wildner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sophie Wildner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sophie Wildner more than expected).
Fields of papers citing papers by Sophie Wildner
This network shows the impact of papers produced by Sophie Wildner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sophie Wildner. The network helps show where Sophie Wildner may publish in the future.
Co-authorship network of co-authors of Sophie Wildner
This figure shows the co-authorship network connecting the top 25 collaborators of Sophie Wildner. A scholar is included among the top collaborators of Sophie Wildner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sophie Wildner. Sophie Wildner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 31 | |
| 3 | 12 | |
| 4 | 29 | |
| 5 | 21 | |
| 6 | 4 | |
| 7 | 69 | |
| 8 | 3 | |
| 9 | INTERIM RESULTS FROM A PHASE IIA STUDY OF THE ANTI-CXCL12 SPIEGELMER OLAPTESED PEGOL (NOX-A12) IN COMBINATION WITH BENDAMUSTINE/RITUXIMAB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA | 2 |
| 10 | 10 | |
| 11 | 0 | |
| 12 | 1 | |
| 13 | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.